H-J. Chen

CTONG 1103: Erlotinib versus gemcitabine plus cisplatin as neo-adjuvant treatment for stage IIIA-N2 EGFR-mutation non-small cell lung cancer (EMERGING): A randomised study.

Q. Wang, W. Zhong, Q. Zhou, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

LncRNA-HEIH suppresses hepatocellular carcinoma cell growth and metastasis by up-regulating miR-199a-3p.

H-J. Chen, W. Shen, M-M Wu, 2020, European review for medical and pharmacological sciences.

LINC00106 prevents against metastasis of thyroid cancer by inhibiting epithelial-mesenchymal transition.

J. Xu, H-J. Chen, G. Zheng, 2020, European review for medical and pharmacological sciences.

Bevacizumab plus chemotherapy for patients with advanced pulmonary adenocarcinoma harboring EGFR mutations

W. Zhong, J. Yang, Y. Wu, 2017, Clinical and Translational Oncology.

Pemetrexed versus gefitinib as a second-line treatment in advanced nonsquamous nonsmall-cell lung cancer patients harboring wild-type EGFR (CTONG0806): a multicenter randomized trial.

Yi-long Wu, W. Feng, W. Zhong, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

Biomarker-integrated study of single agent targeting molecular alterations of PI3KCA, MET, ALK, ROS1, KRAS, NRAS or BRAF in advanced NSCLC: Phase 2 umbrella trial in China (CTONG1505).

Y. Wu, H-J. Chen, A. Myers, 2018, Annals of Oncology.

Roles of circ-CSPP1 on the proliferation and metastasis of glioma cancer.

Q. Lin, M. Li, H-J. Chen, 2020, European Review for Medical and Pharmacological Sciences.